IKARIA, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -.--% |
Ikaria, Inc. is a United States-based company. The Company operates as a biotherapeutics company focused on developing and commercializing therapeutics for critical care. Its INOtherapy is an offering of drug product, services and technologies. Its product INOtherapy includes INOMAX, which is an treatment for hypoxic respiratory failure in term and near-term infants.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +19.96% | 43.32B | |
| +20.38% | 22.81B | |
| +18.59% | 15.32B | |
| +23.93% | 14.91B | |
| +58.23% | 13.23B | |
| -0.05% | 6.79B | |
| -15.52% | 6.51B | |
| -8.87% | 5.73B | |
| +12.39% | 5.53B |
- Stock Market
- Equities
- IKAR Stock
